Timber Creek Capital Management LLC Has $2.71 Million Stock Holdings in Elevance Health, Inc. (NYSE:ELV)

Timber Creek Capital Management LLC boosted its stake in shares of Elevance Health, Inc. (NYSE:ELV) by 17.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 7,350 shares of the company’s stock after buying an additional 1,107 shares during the period. Timber Creek Capital Management LLC’s holdings in Elevance Health were worth $2,711,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of ELV. Raelipskie Partnership bought a new stake in shares of Elevance Health during the third quarter worth $26,000. PSI Advisors LLC acquired a new position in Elevance Health in the 3rd quarter worth $27,000. Eastern Bank bought a new position in Elevance Health during the 3rd quarter worth about $31,000. Dunhill Financial LLC raised its stake in shares of Elevance Health by 57.8% in the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock valued at $37,000 after purchasing an additional 26 shares during the period. Finally, Peterson Financial Group Inc. bought a new stake in shares of Elevance Health in the third quarter valued at about $44,000. 89.24% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on ELV. Stephens downgraded Elevance Health from an “overweight” rating to an “equal weight” rating and decreased their price objective for the stock from $520.00 to $440.00 in a report on Wednesday, January 22nd. Argus reaffirmed a “hold” rating and set a $405.40 price target on shares of Elevance Health in a research report on Wednesday, January 29th. StockNews.com upgraded shares of Elevance Health from a “hold” rating to a “buy” rating in a report on Tuesday, February 4th. Truist Financial reduced their target price on shares of Elevance Health from $520.00 to $480.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, Morgan Stanley decreased their target price on shares of Elevance Health from $643.00 to $551.00 and set an “overweight” rating for the company in a research report on Wednesday, October 23rd. Three analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $517.03.

Elevance Health Trading Down 1.7 %

Elevance Health stock opened at $382.46 on Wednesday. The stock has a 50-day simple moving average of $384.81 and a 200 day simple moving average of $446.05. The stock has a market capitalization of $88.70 billion, a P/E ratio of 14.93, a PEG ratio of 1.17 and a beta of 0.83. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.50 and a current ratio of 1.45. Elevance Health, Inc. has a 52 week low of $362.21 and a 52 week high of $567.26.

Elevance Health (NYSE:ELV) last issued its earnings results on Thursday, January 23rd. The company reported $3.84 EPS for the quarter, topping the consensus estimate of $3.80 by $0.04. Elevance Health had a return on equity of 18.28% and a net margin of 3.38%. Analysts expect that Elevance Health, Inc. will post 34.05 earnings per share for the current year.

Elevance Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Monday, March 10th will be issued a $1.71 dividend. This is an increase from Elevance Health’s previous quarterly dividend of $1.63. This represents a $6.84 annualized dividend and a dividend yield of 1.79%. The ex-dividend date is Monday, March 10th. Elevance Health’s payout ratio is currently 25.46%.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.